ProQR Therapeutics N.V. Total Liabilities
ProQR Therapeutics N.V. (PRQR) had Total Liabilities of EUR 63.38 million as of 2025-12-31, per its 20-F filed 2026-03-12.
Financial Statements › Notes
ifrs-full:Liabilities · last filed 2026-03-12
- 2025-12-31: Liabilities 63.38M EUR.
- 2025-09-30: Liabilities 67.28M EUR.
- 2025-06-30: Liabilities 70.55M EUR.
- 2025-03-31: Liabilities 72.75M EUR.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2025-12-31 | 63.38M EUR 20-F · filed 2026-03-12 | |
| 2025-09-30 | 67.28M EUR 6-K · filed 2025-11-06 | |
| 2025-06-30 | 70.55M EUR 6-K · filed 2025-08-07 | |
| 2025-03-31 | 72.75M EUR 6-K · filed 2025-05-08 | |
| 2024-12-31 | 79.40M EUR 20-F · filed 2026-03-12 | |
| 2024-09-30 | 81.87M EUR 6-K · filed 2024-11-07 | |
| 2024-06-30 | 85.20M EUR 6-K · filed 2024-08-08 | |
| 2024-03-31 | 89.06M EUR 6-K · filed 2024-05-09 | |
| 2023-12-31 | 96.49M EUR 20-F · filed 2025-03-13 | |
| 2023-09-30 | 95.69M EUR 6-K · filed 2023-11-07 | |
| 2023-06-30 | 96.49M EUR 6-K · filed 2023-08-03 | |
| 2023-03-31 | 99.31M EUR 6-K · filed 2023-05-16 | |
| 2022-12-31 | 104.64M EUR 20-F · filed 2024-03-13 | 106.21M EUR 20-F · filed 2023-03-29 |
| 2022-09-30 | 57.19M EUR 6-K · filed 2022-11-09 | |
| 2022-06-30 | 92.08M EUR 6-K · filed 2022-08-04 | |
| 2022-03-31 | 90.02M EUR 6-K · filed 2022-05-05 | |
| 2021-12-31 | 96.35M EUR 20-F · filed 2023-03-29 | |
| 2021-09-30 | 67.31M EUR 6-K · filed 2021-11-04 | |
| 2021-06-30 | 44.81M EUR 6-K · filed 2021-08-05 | |
| 2020-12-31 | 42.18M EUR 20-F · filed 2022-04-29 | |
| 2020-09-30 | 42.10M EUR 6-K · filed 2020-11-16 | |
| 2020-06-30 | 13.93M EUR 6-K · filed 2020-08-06 | |
| 2020-03-31 | 22.28M EUR 6-K · filed 2020-05-07 | |
| 2019-12-31 | 23.70M EUR 20-F · filed 2021-03-24 | |
| 2019-09-30 | 21.64M EUR 6-K · filed 2019-11-12 | |
| 2019-06-30 | 20.02M EUR 6-K · filed 2019-08-07 | |
| 2018-12-31 | 17.55M EUR 20-F · filed 2020-03-31 | |
| 2018-06-30 | 14.81M EUR 6-K · filed 2018-08-08 | |
| 2017-12-31 | 13.78M EUR 20-F · filed 2019-03-28 | |
| 2016-12-31 | 12.41M EUR 20-F · filed 2018-03-30 |